Vanguard Group
KYTH

Vanguard Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Vanguard Group’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-891,025
Closed -$66.8M – 4274
2015
Q3 		$66.8M Buy
891,025
+175,549
+25% +$13.1M ﹤0.01% 1709
2015
Q2 		$53.9M Buy
715,476
+103,098
+17% +$5.52M ﹤0.01% 1897
2015
Q1 		$30.7M Buy
612,378
+128,219
+26% +$5.38M ﹤0.01% 2149
2014
Q4 		$16.8M Buy
484,159
+14,746
+3% +$515K ﹤0.01% 2308
2014
Q3 		$15.4M Buy
469,413
+54,261
+13% +$1.91M ﹤0.01% 2301
2014
Q2 		$15.9M Buy
415,152
+13,651
+3% +$477K ﹤0.01% 2301
2014
Q1 		$16M Buy
401,501
+69,806
+21% +$3.12M ﹤0.01% 2273
2013
Q4 		$12.4M Buy
331,695
+137,984
+71% +$5.72M ﹤0.01% 2364
2013
Q3 		$8.85M Buy
193,711
+36,836
+23% +$1.1M ﹤0.01% 2453
2013
Q2 		$4.24M Buy
+156,875
New +$3.59M ﹤0.01% 2756

Vanguard Group's KYTH Position: Q4 2015 in Review

Vanguard Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 891,025 shares — an estimated $66.8M sold.

Vanguard Group first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $66.8M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Vanguard Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Vanguard Group sold 891,025 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $66.8M.
  • Vanguard Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Vanguard Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $66.8M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Vanguard Group's 13F filing for Q4 2015, filed 8 Feb 2016.